Meet the training leader
- Prof. Dr. Tudor Arvinte
- Titular Professor of Biopharmaceutics, School of Pharmaceutical Sciences, University of Geneva, and CEO
- Therapeomic, Inc. Basel, Switzerland
Key topics
Key takeaways
Learn more
Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions
Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration
Defining the right diluent for intravenous infusion of therapeutic antibodies
Contact us
- Andrea Weber
- Sr. Manager for Pharma
- Phone: +421 257 272 232
- Email: event.inquiries@fleming.events